{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:51:50Z","timestamp":1782276710579,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.clinbiochem.2007.10.015","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T07:12:14Z","timestamp":1195024334000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"41","author":[{"given":"Hiroko","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Hina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Sogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Shinohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Kusachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2007.10.015_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","article-title":"Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure","volume":"90","author":"Yasue","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib2","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1210\/endo-126-4-2225","article-title":"Rat brain natriuretic peptide-tissue distribution and molecular form","volume":"126","author":"Ogawa","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.RES.69.2.491","article-title":"Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide","volume":"69","author":"Ogawa","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib4","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.CIR.92.6.1558","article-title":"Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction","volume":"92","author":"Hama","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.HYP.17.6.1152","article-title":"Expression of brain natriuretic peptide gene in human heart. Production in the ventricle","volume":"17","author":"Hosoda","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/eurheartj\/ehi236","article-title":"Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease","volume":"26","author":"Weber","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/hrt.76.3.232","article-title":"Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment","volume":"76","author":"Omland","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib9","first-page":"740","article-title":"Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?","volume":"44","author":"Rodeheffer","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","article-title":"Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction","volume":"96","author":"Tsutamoto","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2796.1997.00184.x","article-title":"Brain natriuretic peptide in an elderly population","volume":"242","author":"Wallen","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2003.07.010","article-title":"Brain natriuretic peptide is elevated in outpatients with atrial fibrillation","volume":"92","author":"Silvet","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.amjcard.2004.03.013","article-title":"Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation","volume":"93","author":"Wozakowska-Kaplon","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib14","first-page":"1245","article-title":"Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm","volume":"20","author":"Beck-da-Silva","year":"2004","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000081009","article-title":"Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm","volume":"102","author":"Vinch","year":"2004","journal-title":"Cardiology"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198903233201201","article-title":"Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population","volume":"320","author":"Spirito","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/hrt.32.5.652","article-title":"Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis","volume":"32","author":"Glancy","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(97)01282-8","article-title":"Hypertrophic cardiomyopathy","volume":"350","author":"Maron","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/oxfordjournals.eurheartj.a060366","article-title":"Supraventricular arrhythmia as the cause of sudden death in hypertrophic cardiomyopathy","volume":"15","author":"Madariaga","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","article-title":"Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population","volume":"26","author":"Cecchi","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1071-9164(00)90010-1","article-title":"Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation","volume":"6","author":"Inoue","year":"2000","journal-title":"J Card Fail"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib23","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/eurheartj\/ehl176","volume":"27","author":"Fuster","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.28.1.22","article-title":"Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension","volume":"28","author":"Nishikimi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib25","first-page":"2","article-title":"An immunoradiometric assay for brain natriuretic peptide in human plasma (in Japanese with English abstract)","volume":"13","author":"Kono","year":"1992","journal-title":"Jpn J Nucl Med Technol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib26","first-page":"1091","volume":"16","author":"Cheitlin","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib27","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib29","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0002-9149(79)90160-7","article-title":"Hypertrophic cardiomyopathy: a discussion of nomenclature","volume":"43","author":"Maron","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2005.05.057","article-title":"Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study","volume":"46","author":"Knudsen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJM197102252840805","article-title":"Decision-making studies in patient management","volume":"284","author":"Lusted","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib32","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion (with discussion)","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1253\/circj.69.277","article-title":"Clinical characteristics of heart disease patients with a good prognosis in spite of markedly increased plasma levels of type-B natriuretic peptide (BNP): anomalous behavior of plasma BNP in hypertrophic cardiomyopathy","volume":"69","author":"Takeuchi","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000117098.75727.D8","article-title":"Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy","volume":"109","author":"Maron","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2004.10.046","article-title":"Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation","volume":"105","author":"Engelmann","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00380-005-0884-y","article-title":"B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation","volume":"21","author":"Li","year":"2006","journal-title":"Heart Vessels"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2004.02.010","article-title":"Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"17","author":"Tani","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2003.01.001","article-title":"P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Ozdemir","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2007.10.015_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/hrt.78.1.44","article-title":"Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration","volume":"78","author":"Cecchi","year":"1997","journal-title":"Heart"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912007004043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912007004043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:28:32Z","timestamp":1757863712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912007004043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0009912007004043"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.10.015","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}